MA45283A1 - Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela - Google Patents

Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela

Info

Publication number
MA45283A1
MA45283A1 MA45283A MA45283A MA45283A1 MA 45283 A1 MA45283 A1 MA 45283A1 MA 45283 A MA45283 A MA 45283A MA 45283 A MA45283 A MA 45283A MA 45283 A1 MA45283 A1 MA 45283A1
Authority
MA
Morocco
Prior art keywords
capsular
protein conjugates
transporter protein
pneumococcal polysaccharide
multivalent composition
Prior art date
Application number
MA45283A
Other languages
English (en)
Other versions
MA45283B1 (fr
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MA45283A1 publication Critical patent/MA45283A1/fr
Publication of MA45283B1 publication Critical patent/MA45283B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une composition de vaccin comprenant 13 ou 14 types de conjugués de protéine de transport de polysaccharide capsulaire pour la prévention de maladies à pneumocoque et une composition immunogène pour streptococcus pneumoniae.
MA45283A 2016-09-06 2017-08-31 Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela MA45283B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (fr) 2016-09-06 2017-08-31 Composition comprenant une protéine multivalent de transport de polysaccharide capsulaire et son utilisation

Publications (2)

Publication Number Publication Date
MA45283A1 true MA45283A1 (fr) 2019-06-28
MA45283B1 MA45283B1 (fr) 2021-05-31

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45283A MA45283B1 (fr) 2016-09-06 2017-08-31 Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela

Country Status (12)

Country Link
KR (1) KR101991457B1 (fr)
BR (1) BR112019004303A2 (fr)
EA (1) EA201990451A1 (fr)
JO (1) JOP20190038B1 (fr)
MA (1) MA45283B1 (fr)
MX (1) MX2019002552A (fr)
MY (1) MY192792A (fr)
PH (1) PH12019500377A1 (fr)
SA (1) SA519401232B1 (fr)
TN (1) TN2019000064A1 (fr)
WO (1) WO2018048141A1 (fr)
ZA (1) ZA201901969B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117982633A (zh) 2017-12-06 2024-05-07 默沙东有限责任公司 包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法
JP6950099B2 (ja) 2018-02-05 2021-10-13 サノフィ パスツール インコーポレイティッド 多価肺炎球菌多糖体−タンパク質複合体組成物
EP3782642A4 (fr) * 2018-04-18 2022-04-13 SK Bioscience Co., Ltd. Polysaccharides capsulaires de streptococcus pneumoniae et conjugués immunogènes de ceux-ci
SG11202106541WA (en) 2018-12-19 2021-07-29 Merck Sharp & Dohme Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2023218322A1 (fr) * 2022-05-11 2023-11-16 Pfizer Inc. Procédé de production de formulations de vaccin avec des conservateurs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE254475T1 (de) * 1993-09-22 2003-12-15 Jackson H M Found Military Med Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
IL308456A (en) * 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
AU2011262346B2 (en) * 2010-06-04 2014-12-11 Wyeth Llc Streptococcus pneumoniae vaccine formulations
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
CN104069504B (zh) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 一种增强多糖蛋白结合物免疫原性的方法

Also Published As

Publication number Publication date
BR112019004303A2 (pt) 2019-05-28
EA201990451A1 (ru) 2019-08-30
MA45283B1 (fr) 2021-05-31
JOP20190038A1 (ar) 2019-03-06
SA519401232B1 (ar) 2022-10-23
WO2018048141A1 (fr) 2018-03-15
MY192792A (en) 2022-09-09
JOP20190038B1 (ar) 2023-09-17
MX2019002552A (es) 2019-07-01
KR20180027353A (ko) 2018-03-14
KR101991457B1 (ko) 2019-09-30
ZA201901969B (en) 2019-12-18
TN2019000064A1 (en) 2020-07-15
PH12019500377A1 (en) 2019-10-21

Similar Documents

Publication Publication Date Title
MA45283A1 (fr) Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CY1123783T1 (el) Antiσωμαta enanti-b7-h3 και συζευγματα αντισωματος φαρμακου
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
BR112020004471A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
BR112020004396A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
MX2022009928A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
BR112016016580A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados dos mesmos
MX2019002968A (es) Un complejo novedoso que comprende un peptido penetrante de celulas, una carga y un agonista de peptido de tlr para tratamiento de cancer colorrectal.
MX2020002555A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX2016003621A (es) Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3.
TN2015000402A1 (fr) Methods for treating crohn's disease using an anti-il23 antibody
WO2015175355A8 (fr) Compositions et procédés d'augmentation de l'immunogénicité de conjugués polysaccharide-protéine
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
MA46661B1 (fr) Formulations de vaccin glycoconjugué dirigé contre expec
CO2021007863A2 (es) Vacuna conjugada polisacárido-proteína neumocócica multivalente
MX2018008300A (es) Formulacion para anticuerpo y conjugado de farmaco del mismo.
WO2016198170A8 (fr) Vaccins contre le sérotype 5 de streptococcus pneumoniae
MX2022001937A (es) Composicion inmunogenica.
AR114693A1 (es) Vacunas contra infecciones intraabdominales
TH175548A (th) วัคซีนโรคมือ เท้า และปาก ตลอดจนวิธีการในการผลิตและการใช้วัคซีนดังกล่าว